Simplify Asset Management Inc. purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,085 shares of the semiconductor company’s stock, valued at approximately $535,000.
A number of other institutional investors have also recently bought and sold shares of the business. Ethic Inc. increased its holdings in shares of Synopsys by 17.3% in the 3rd quarter. Ethic Inc. now owns 20,193 shares of the semiconductor company’s stock valued at $9,963,000 after purchasing an additional 2,972 shares during the period. Three Seasons Wealth LLC purchased a new position in Synopsys during the third quarter valued at approximately $694,000. Everpar Advisors LLC increased its stake in Synopsys by 8.2% in the 3rd quarter. Everpar Advisors LLC now owns 883 shares of the semiconductor company’s stock valued at $436,000 after buying an additional 67 shares during the period. Perigon Wealth Management LLC lifted its position in Synopsys by 14.4% in the 3rd quarter. Perigon Wealth Management LLC now owns 2,438 shares of the semiconductor company’s stock worth $1,203,000 after buying an additional 306 shares in the last quarter. Finally, Sowell Financial Services LLC lifted its position in Synopsys by 4.3% in the 3rd quarter. Sowell Financial Services LLC now owns 1,035 shares of the semiconductor company’s stock worth $511,000 after buying an additional 43 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $478.97 on Tuesday. The business’s 50-day simple moving average is $438.09 and its 200-day simple moving average is $503.51. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The firm has a market cap of $91.64 billion, a price-to-earnings ratio of 59.95, a P/E/G ratio of 3.97 and a beta of 1.16.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on SNPS. Robert W. Baird reaffirmed a “neutral” rating and issued a $535.00 price target (down from $670.00) on shares of Synopsys in a research note on Wednesday, September 10th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Rosenblatt Securities raised Synopsys from a “neutral” rating to a “buy” rating and cut their price target for the stock from $605.00 to $560.00 in a research note on Tuesday, December 9th. Morgan Stanley lifted their price target on Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Finally, Wells Fargo & Company boosted their price target on Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research note on Thursday, December 11th. Eleven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $562.13.
Get Our Latest Stock Analysis on SNPS
Insider Transactions at Synopsys
In related news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.62% of the company’s stock.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Wall Street Stockpicker Names #1 Stock of 2026
- ALERT: Drop these 5 stocks before January 2026!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Your “birthright claim” just got activated
- Chilling warning from legendary investor
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
